You go for a routine fertility check. The doctor orders a blood test and, a few days later, mentions your AMH is low. For most women, that single sentence without context is terrifying. But what does AMH actually measure, and does a low score mean you cannot get pregnant?
The answer is more nuanced and more hopeful than many women are led to believe.
What Is AMH?
AMH stands for Anti-Mullerian Hormone. Substances secreted by small follicles in the ovary are clinical biomarkers used to measure ovarian reserve, that is, the number of a womanβs remaining eggs.
Unlike other routine menstrual hormone tests, whose levels fluctuate across the menstrual cycle, AMH levels remain stable. It can be tested on any day of a natural menstrual cycle and serves as a reliable, popular fertility screening tool in fertility clinics.
Normal AMH levels vary by age. What is considered low for a 28-year-old may be entirely expected for a 40-year-old. Context always matters.
What Does Low AMH Actually Mean?
A low AMH score tells you that your remaining egg count is lower than expected for your age. What it does not directly tell you is the quality of those eggs.
Many women with low AMH conceive naturally or through IVF with their own eggs. What low AMH does indicate is that time may be a factor and that acting sooner rather than later is generally advisable.
Low AMH is commonly seen in women with premature ovarian insufficiency, those who have undergone chemotherapy or ovarian surgery, women with a family history of early menopause, and increasingly, younger women in their late 20s and early 30s with no obvious cause of growing concern in India.
AMH and IVF: Why It Matters
In assisted reproduction, during IVF cycles, AMH can predict the number of eggs that can be retrieved via oocyte retrieval. Women with low AMH levels are poor responders; even when treated with the maximum dose of ovulation-inducing medication, they only develop a minimal number of follicles.
This is where the focus on egg quality becomes especially important. When the number of eggs retrieved is limited, every single egg counts. Poor responders and women with low ovarian reserve significantly benefit from pre-IVF preparation that focuses on optimising the quality of existing eggs rather than just increasing their quantity.
Mitochondrial support plays a central role here. Eggs rely on mitochondrial energy to complete their maturation and fertilisation. For women with low AMH, supporting oocyte mitochondrial health in the months before IVF can improve fertilisation rates and embryo quality even when fewer eggs are retrieved.
MITOV, India’s first mitochondrial optimiser, is specifically indicated for low ovarian reserve and poor responders, addressing this gap by supporting follicular health and oocyte energy at the cellular level during the preparation phase.
Can AMH Be Improved?
AMH itself cannot be significantly raised; it reflects the number of follicles remaining, and that pool naturally declines over time. However, the quality of the eggs within that pool can be supported and optimized.
This is why the clinical focus for women with low AMH has shifted toward ovarian environment improvement, reducing inflammation, supporting antioxidant defence, and optimising mitochondrial function so that the existing eggs have the best possible chance of maturing, fertilising, and developing into healthy embryos.
What Should Women with Low AMH Do?
- If you require a fertility assessment, you may consult a reproductive endocrinology or fertility specialist, who will evaluate your AMH level by integrating your full hormone profile, antral follicle count, and personal medical history.
- Initiate preparations for the preconception period as early as possible and capitalise on the 90-day window to improve oocyte quality.
- Patients identified as poor responders in assisted reproduction should first consult a physician before using any targeted supplements.
- Consider the timing of any planned IVF carefully, as acting sooner preserves more options.
The Bottom Line.
Low AMH is a signal, not a sentence. It tells you that your ovarian reserve needs attention and that time is a factor, but it does not eliminate your chances of pregnancy. Many women with low AMH achieve successful pregnancies with the right preparation, medical support, and a focus on egg quality over egg count.
If you have received a low AMH result, let it be the prompt that moves you toward action, not the reason to give up.
Frequently Asked Questions
1. What is a normal AMH level for women trying to conceive?
Anti-Mullerian hormone (AMH) levels vary with age. In general, an AMH level β₯1.0 ng/mL indicates sufficient ovarian reserve, while a level of 0.5β1.0 ng/mL may signal reduced ovarian reserve. However, results must be interpreted by a physician in combination with the patientβs age, antral follicle count, and overall hormone profile; patients must not misjudge their test results on their own.
2. Can I get pregnant naturally with low AMH?
Yes, many women with low AMH conceive naturally. Low AMH indicates a smaller remaining egg pool, not the absence of high-quality eggs. Women with low AMH are advised to act sooner rather than later and to focus on optimising egg quality during the 90-day maturation window.
3. Does low AMH mean my eggs are of poor quality?
Not necessarily. AMH measures the quantity of remaining follicles, not the quality of those eggs. Two women with the same low AMH can have very different egg quality. This is why the focus for low AMH patients shifts to supporting and optimising the quality of the eggs available.
4. How does MITOV help women with low AMH?
The assisted reproductive drug MITOV is indicated for patients with diminished ovarian reserve and poor IVF response. It supports the mitochondrial function of mature oocytes, improves fertilisation potential and embryo quality, and maximises the utilisation of a patientβs limited number of eggs.
(Message in Public Interest by Surishi Academic Council | Makers of MITOV)
